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When the Circadian Clock Meets the
Melanin Pigmentary System
Andrzej T. Slominski1,2, Ru¨diger Hardeland3 and Russel J. Reiter4
Silencing of BMAL1 and PER1 stimulates melanogenic activity of follicular and
epidermal melanocytes, indicating a novel role for peripheral circadian clock
processes in the regulation of melanin pigmentation. Linking the expression levels
of BMAL1/PER1 with changes in melanogenesis opens exciting opportunities to
study the role of the local molecular clock in modulation of melanocyte functions
in the hair follicle and the epidermis with attendant effects on epidermal barrier
functions in general.
Journal of Investigative Dermatology (2015) 135, 943–945; doi:10.1038/jid.2014.553
Silencing of the BMAL1 and PER1
stimulates melanogenic apparatus in
the skin
In this issue, Hardman et al. (2015)
provide evidence for the involvement
of a peripheral circadian oscillator in
the control of human pigmentation.
The experiments were conducted
using micro-dissected hair follicles and
cultured primary skin melanocytes.
Although melanogenesis in the hair
follicle is anagen-associated (Slominski
and Paus, 1993), the role of the peri-
pheral clock was notably demonstrated
under the conditions independent of the
hair cycle (Hardman et al., 2015).
Conclusions were convincingly drawn
from silencing of either BMAL1 (brain
and muscle aryl hydrocarbon receptor
nuclear translocator-like 1) or PER1
(period 1), using respective small
interfering RNAs. These two proteins
are components of the circadian core
oscillator, in which a heterodimer
formed from BMAL1 and its interaction
partner CLOCK (circadian locomotor
output cycles kaput) stimulates the
expression of PER (period) and CRY
(cryptochrome) variants. These factors
jointly block BMAL1/CLOCK actions, a
fundamental basis for the cyclicity of
circadian oscillators. The BMAL1/
CLOCK heterodimer activates PER and
CRY expression by binding to an E-box
within the respective promoters. In
addition, BMAL1/CLOCK stimulates the
expression of various circadian-driven
genes carrying an E-box. Concerning
melanogenesis, E-boxes are found in
the genes of tyrosinase, tyrosinase-
related proteins 1 and 2, in which they
also act as binding sites of the
melanogenic master regulator MITF
(microphthalmia-associated transcrip-
tion factor; Slominski et al., 2004).
With regard to the circadian oscillator
mechanism, silencing of BMAL1 can be
expected to substantially decrease
PER1 expression. In a cycling oscillator,
PER/CRY heterodimers are the key
players of the negative feedback limb
downregulating BMAL1/CLOCK activity.
However, silencing of PER1 may not
necessarily lead to BMAL1 overexpres-
sion, as in knockdown experiments
the oscillator is more or less fixed in a
non-cycling phase of the artificially
deregulated oscillator.
Under these conditions, silencing of
either BMAL1 or PER1 led to remarkably
clear effects: increased pigmentation,
expression of tyrosinase, tyrosinase-
related proteins 1 and 2, and phosphor-
ylation of the melanogenic master
regulator MITF. Silencing of PER1
caused mostly stronger effects than that
of BMAL1, findings that may indicate a
greater importance of the PER protein in
stimulating melanogenesis, perhaps also
under cycling conditions. In addition to
the molecular data, increased numbers
of melanosomes, higher melanocyte
dendricity, and stimulation of melano-
some transfer to keratinocytes were
shown to result from PER1 silencing,
which likely indicates involvement of
extramelanocytic cutaneous signaling
systems (Slominski et al., 2012). Com-
parison of hair follicle explants with
melanocyte cultures allowed a dissec-
tion between cell-autonomous actions
and other effects requiring cell–cell inter-
actions. In the isolated melanocytes,
silencing of the core oscillator compo-
nents increased melanogenesis, whereas
gp100 expression and melanocyte den-
dricity were not substantially changed
and may thus require melanocyte–
keratinocyte interactions, as reviewed by
Slominski et al. (2004).
BMAL1 and PER1 affect
melanin pigmentation.
Central and peripheral regulators of
circadian rhythm
During recent years, abundant evidence
has accumulated regarding the impor-
tance of peripheral circadian oscillators
(Fu and Kettner, 2013; Hardeland,
2013; Reiter et al., 2014). Some of
these cellular clocks are to a variable
extent autonomous and do not receive a
direct input from the hypothalamic
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pacemaker, the suprachiasmatic nucleus
(SCN) (Hardeland, 2013). However, they
may be indirectly influenced by SCN-
dependent cycles, such as the rhythms of
glucocorticoids, ACTH, or melatonin. It
must be noted that melatonin (Slominski
et al., 2008; Hardeland, 2013; Reiter
et al., 2014), ACTH, and glucocor-
ticoids are also produced in peripheral
organs including the skin (Slominski
et al., 2013). The partial autonomy of
peripheral cellular clocks must also be
considered in the context of the cell
cycle, which is gated by the respective
circadian oscillator via controlling G1-,
intra-S-, and G2/M checkpoints and
modulating mitogenic signals (Fu and
Kettner, 2013). The circadian influence
on cell division, as controlled by different
clocks, is usually cell type–specific.
Skin and local circadian clock
In the skin, the gating of cell cycle
progression by a peripheral clock has
been recently addressed in the context
of regenerative hair cycling, uncovering
diurnal mitotic gating as an essential
mechanism protecting anagen hair folli-
cle (Plikus et al., 2013). The study by
Hardman et al., (2015) explored an
additional role of a peripheral circadian
oscillator on melanin formation in hair
follicles and epidermal melanocytes. In
this context, it is important to mention
that different signaling molecules includ-
ing melatonin, ACTH, and cortisol,
whose systemic fluctuation is regulated
by the central pacemaker, are also
produced in the skin and are involved
in the regulation of hair and epidermal
functions (Slominski et al., 2012, 2013,
2014). As these factors are also produced
in melanocytes, the challenge for
future research is to determine whether
their local production as well as their
receptors are regulated by a peripheral
circadian clock, and how these cycling
cascades affect final skin phenotype.
Dermatological implications
The study by Hardman et al., (2015),
although limited to the pigmentary
system, suggests a multitude of possi-
bilities in experimental and clinical
dermatology. Knowing that the clock
influences melanin formation and mela-
nosome transfer, the anagen-associated
processes of pigmentation can be anal-
yzed in-depth from a new perspective.
One may consider other aspects of cell
cycle control and the roles of accessory
oscillator components that are asso-
ciated with or driven by core oscillator
proteins. This may be the case for the
PER1-associated factor NONO (non-
POU domain-containing octamer bind-
ing protein), which has been reported to
couple the circadian oscillator to the
cell cycle (Kowalska et al., 2013).
Another area that can be explored in
the pigmentary system is the role of the
aging suppressor sirtuin 1 (SIRT1), which
has been shown to associate with
BMAL1/CLOCK dimers (Sahar and
Sassone-Corsi, 2013). In various peri-
pheral circadian oscillators, the surpris-
ing observation has been made that
neither CLOCK nor SIRT1 expression is
rhythmic. However, contrary to protein
levels, the activities of SIRT1 and, thus,
of the BMAL1/CLOCK/SIRT1 complex
do exhibit rhythms, because the stabi-
lity of the ternary complex depends on
the SIRT1 substrate NADþ , which
exhibits a rhythm due to the E-box-
controlled expression of nicotinamide
phosphoribosyltransferase, which regu-
lates NADþ formation (Sahar and
Sassone-Corsi, 2013). This would repre-
sent an unexpected but exciting area of
research in skin biology in general and
interaction between melanogenesis and
cellular metabolism (Slominski et al.,
2014).
Finally, the role of BMAL1, PER1, or
other circadian regulators should also be
explored in the development and pro-
gression of melanoma, a tumor of mel-
anocytic origin. This may identify novel
therapies for this devastating disease.
This possibility is strengthened by the
well-known deregulation of circadian
oscillators in other tumor cells (Fu and
Kettner, 2013; Hardeland, 2013; Reiter
et al., 2014).
Concluding remarks
This work (Hardman et al., 2015) from
Dr Paus’ group opens a ‘‘Pandora’s
box’’ of possibilities that relate
not only to regulation of melanin
pigmentation by BMAL1 and PER1 but
also to the role of peripheral circadian
rhythms in regulation of skin physiology
overall, with important health-care
implications. The biggest challenge is
to decipher how the local neuro-
endocrine systems are integrated and
participate in proper function of
the molecular clock that would also
include melatonin, glucocorticoids,
ACTH, and other signals/messengers
now associated with the systemic
circadian clock but which also operate
on the local level (Hardeland, 2013;
Slominski et al., 2013; Reiter et al.,
2014; Slominski et al., 2014).
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Hsp90 Inhibitor Can Inhibit
UV Carcinogenesis
Santosh K. Katiyar1,2
Extensive exposure to solar UVR is a well-recognized etiologic factor for
cutaneous non-melanoma skin cancer. In this issue of the Journal, Singh et al.
show that topical treatment of the skin with 17-[allylamino]-17-demethoxygelda-
namycin (17AAG), a heat-shock protein 90 (Hsp90) inhibitor, prevents UVR-
induced squamous cell carcinomas (SCCs) in mice. The inhibitory effect of 17AAG
on SCC was associated with the inhibition of the UVR-induced (i) hyperplastic
response, (ii) Hsp90b-PKCe interaction, and (iii) pStat3 and pAkt expression in
mouse skin.
Journal of Investigative Dermatology (2015) 135, 945–947; doi:10.1038/jid.2014.504
Epidemiological, clinical, and labora-
tory studies have implicated solar UVR
in tumor initiation, tumor promotion,
and complete carcinogenesis. Excessive
exposure to UVR can lead to the initia-
tion and development of several skin
disorders/diseases and increase the risk
of melanoma and non-melanoma skin
cancers (Baliga and Katiyar, 2006). UVR
exposure induces inflammatory respon-
ses, oxidative stress, immunosuppres-
sion, DNA damage, and gene mut-
ations. Individually, each of these
effects can contribute to the risk of
skin cancers, and collectively they
heighten the risk considerably.
Multiple molecular targets and
biomarkers have been identified,
which have significant roles in skin
diseases. Efforts have been made to
develop new and more effec-
tive strategies for the treatment and/or
prevention of these skin diseases. For
more than two decades, efforts have
been concentrated on screening and
testing the chemopreventive effects
of natural plant products or phyto-
chemicals using various animal models.
Phytochemicals, including dietary plant
products, offer promising options for the
development of more effective chemo-
preventive or chemotherapeutic strate-
gies for cancers of different organs
including the skin. These alternative
strategies are based upon the specific
characteristics of the individual phyto-
chemicals, such as their anti-inflam-
matory, antioxidant, DNA repair activi-
ties and their ability to stimulate the
immune system. In line with these
investigations and strategies, green tea
polyphenols, grape seed proantho-
cyanidins, and silymarin have been
studied extensively, and these phyto-
chemicals have shown significant anti-
skin carcinogenesis effects both in
in vitro and in vivo in animal models
(Baliga and Katiyar, 2006; Nichols and
Katiyar, 2010). Multiple molecular tar-
gets, including inflammatory mediators,
oxidative stress, DNA damage and
repair, and immunological responses,
have been identified that are respon-
sible for the prevention of UVR-induced
skin carcinogenesis by these phyto-
chemicals.
The research laboratory of Dr Verma
and colleagues reported the activation
of protein kinase Ce (PKCe), a novel
PKC isoform, in UV-exposed skin and
demonstrated that PKCe activation
mediates UVR-induced tumor necrosis
factor-a release, which is linked to the
development of squamous cell carcino-
mas (SCCs; Wheeler et al., 2004). PKCe
is among the six PKC isoforms (a, d, e, m,
x, and Z) that are expressed in both
human and mouse skin. PKCe over-
expression decreased the latency while
increasing the incidence and multi-
plicity of the SCCs in PKCe transgenic
mice (Wheelar et al., 2004). It has been
reported that the possible mechanisms
by which PKCe mediates susceptibility
to SCC induction include PKCe-medi-
ated anti-apoptotic and cell survival
signals (Aziz et al., 2007). The PKCe-
mediated cell survival signal may
involve interaction of PKCe with Stat3,
which also has been linked to the
induction of skin cancer (Goetz et al.,
2005).
In this issue, Singh et al. (2015) have
shown that UVR exposure increases the
interaction of PKCe with heat-shock
protein 90b (Hsp90b) and that this
interaction may have an important role
in UVR-induced SCCs. The chaperone
Hsp90 mediates the maturation and
stabilization of PKCe as a client protein
(Gould et al., 2009) and also has a
significant role in cell transformation,
proliferation, and cell survival (Miyata
et al., 2013). Hsp90 is of considerable
interest as an oncogenic target as tumor
cells and oncogenic proteins are heavily
dependent on its activity (Soti et al.,
2005). By inhibiting Hsp90 one can
target a large number of downstream
proteins and thereby attack the neo-
plastic process at several points as
illustrated in Figure 1. Consequently,
several Hsp90 inhibitors have been
developed and are being evaluated for
treatment of various human cancers
(Cullinan and Whitesell, 2006). Gelda-
namycin, the first Hsp90 inhibitor to be
tested in a clinical trial, failed because
of hepatotoxicity. Second-generation
derivatives, such as 17-[allylamino]-17-
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